Arnaud Lesegretain

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “FLT3 inhibitors upregulate CXCR4 and E-selectin ligands through suppression of ERK in AML and combined inhibition of CXCR4/E-selectin enhances anti-leukemia efficacy of FLT3-targeted therapy”.

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands through suppression of ERK in AML and combined inhibition of CXCR4/E-selectin enhances anti-leukemia efficacy of FLT3-targeted therapy

Research Square(2022)10.21203/rs.3.rs-2277452/v1

N/A

0.104DataRank · unranked

1 citations

Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren B. Ostermann, Jared K. Burks +11 more

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

Leukemia(2023)10.1038/s41375-023-01897-x

N/A

0DataRank · unranked

19 citations

Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren B. Ostermann, Jared K. Burks +11 more